Johnson Investment Counsel Inc Novartis Ag Transaction History

Johnson Investment Counsel Inc

  • $10.1 Billion
  • Q3 2024

A detailed history of Johnson Investment Counsel Inc transactions in Novartis Ag stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 18,540 shares of NVS stock, worth $1.83 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,540
Previous 19,204 3.46%
Holding current value
$1.83 Million
Previous $2.04 Million 4.31%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$106.13 - $120.89 $70,470 - $80,270
-664 Reduced 3.46%
18,540 $2.13 Million
Q2 2024

Aug 08, 2024
BUY
$92.57 - $107.37 $11,293 - $13,099
122 Added 0.64%
19,204 $2.04 Million
Q1 2024

May 09, 2024
BUY
$95.27 - $108.47 $36,869 - $41,977
387 Added 2.07%
19,082 $1.85 Million
Q4 2023

Feb 07, 2024
BUY
$92.27 - $101.54 $130,285 - $143,374
1,412 Added 8.17%
18,695 $1.89 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $97,571 - $108,283
1,030 Added 6.34%
17,283 $1.76 Million
Q2 2023

Aug 10, 2023
BUY
$92.52 - $104.91 $3,423 - $3,881
37 Added 0.23%
16,253 $1.64 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $27,610 - $32,019
-345 Reduced 2.08%
16,216 $1.49 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $216,450 - $265,069
2,865 Added 20.92%
16,561 $1.5 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $16,861 - $19,720
226 Added 1.68%
13,696 $1.04 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $15,459 - $18,000
192 Added 1.45%
13,470 $1.14 Million
Q1 2022

May 11, 2022
SELL
$80.11 - $90.62 $39,013 - $44,131
-487 Reduced 3.54%
13,278 $1.17 Million
Q4 2021

Feb 15, 2022
BUY
$79.7 - $88.13 $956 - $1,057
12 Added 0.09%
13,765 $1.2 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $8,586 - $9,989
-105 Reduced 0.76%
13,753 $1.13 Million
Q2 2021

Aug 13, 2021
SELL
$85.24 - $94.15 $2,812 - $3,106
-33 Reduced 0.24%
13,858 $1.26 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $14,195 - $16,739
-170 Reduced 1.21%
13,891 $1.19 Million
Q4 2020

Feb 12, 2021
BUY
$78.07 - $94.43 $29,900 - $36,166
383 Added 2.8%
14,061 $1.33 Million
Q3 2020

Nov 16, 2020
SELL
$82.14 - $91.0 $7,885 - $8,736
-96 Reduced 0.7%
13,678 $1.19 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $11,572 - $13,027
-143 Reduced 1.03%
13,774 $1.2 Million
Q1 2020

May 20, 2020
SELL
$70.67 - $99.01 $86,641 - $121,386
-1,226 Reduced 8.1%
13,917 $1.15 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $25,051 - $28,324
297 Added 2.0%
15,143 $1.43 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $85,026 - $93,694
-994 Reduced 6.28%
14,846 $1.29 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $19,981 - $24,592
-265 Reduced 1.65%
15,840 $1.45 Million
Q1 2019

May 13, 2019
SELL
$75.32 - $86.15 $150,112 - $171,696
-1,993 Reduced 11.01%
16,105 $1.55 Million
Q4 2018

Feb 13, 2019
BUY
$73.66 - $82.02 $109,385 - $121,799
1,485 Added 8.94%
18,098 $1.55 Million
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $535 - $619
8 Added 0.05%
16,613 $1.43 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $286,123 - $323,370
-4,408 Reduced 20.98%
16,605 $1.25 Million
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $29,352 - $35,090
-417 Reduced 1.95%
21,013 $1.7 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $107,120 - $114,984
1,481 Added 7.42%
21,430 $1.8 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $1.48 Million - $1.54 Million
19,949
19,949 $1.71 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email